Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fractyl Health Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GUTS
Nasdaq
8731
https://www.fractyl.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fractyl Health Inc
The 3 Most Volatile Stocks for Short-Term Traders: April 2024
- Apr 17th, 2024 7:10 pm
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
- Apr 2nd, 2024 12:00 pm
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Apr 1st, 2024 11:00 am
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
- Apr 1st, 2024 10:00 am
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
- Mar 12th, 2024 6:06 pm
Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
- Mar 12th, 2024 12:38 pm
Analysts Bet Big on These Beaten-Down IPO Stocks
- Mar 3rd, 2024 6:13 pm
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
- Feb 20th, 2024 1:38 pm
Fractyl Health Announces Pricing of Initial Public Offering
- Feb 2nd, 2024 1:08 am
Scroll